MedPath
NMPA Approval

Tocilizumab Injection (Subcutaneous Injection)

国药准字SJ20220013

April 8, 2022

Drug Information

托珠单抗注射液(皮下注射)

注射剂

162mg/0.9ml/支

生物制品

April 8, 2022

April 7, 2027

Company Information

Applicant Company

Emil-Barell-Strasse 1, 79639 Grenzach-Wyhlen, Germany

Manufacturing Company

Schützenstrasse 87 and 99-101, 88212 Ravensburg, Germany

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

托珠单抗注射液(皮下注射) - NMPA 批准文号 | MedPath